Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.3751
+0.0401 (11.97%)
At close: May 12, 2025, 4:00 PM
0.3631
-0.0120 (-3.20%)
After-hours: May 12, 2025, 7:25 PM EDT
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $15.48 million as of May 12, 2025. Its market cap has decreased by -81.62% in one year.
Market Cap
15.48M
Enterprise Value
-31.97M
1-Year Change
-81.62%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $15.48M, a decrease of -79.03%. That is a compound annual growth rate of -17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 13.80M | -87.48% |
| Dec 31, 2024 | 110.20M | 3.96% |
| Dec 29, 2023 | 106.00M | 137.67% |
| Dec 30, 2022 | 44.60M | -84.42% |
| Dec 31, 2021 | 286.20M | 113.26% |
| Dec 31, 2020 | 134.20M | 395.20% |
| Dec 31, 2019 | 27.10M | -7.82% |
| Dec 31, 2018 | 29.40M | -49.83% |
| Dec 29, 2017 | 58.60M | -20.60% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |